Lactose (India) (BOM:524202) Additional Paid-In Capital: ₹0 Mil(As of Mar. 2026)


BOM:524202 Lactose (India) Ltd BOM:524202
77 GF Score
Price ₹101.30
GF Value ₹160.18
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Lactose (India) Additional Paid-In Capital?

Lactose (India) BOM:524202 -2.74% 77 Additional Paid-In Capital is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:524202 with a GF Score™ of 77/100 and a GF Value™ of ₹160.18 (Significantly Undervalued). The stock has 4 warning signs investors should review.


Lactose (India)'s annual additional paid-in capital stayed the same from Mar. 2024 (₹131 Mil) to Mar. 2025 (₹131 Mil) but then declined from Mar. 2025 (₹131 Mil) to Mar. 2026 (₹0 Mil).

Lactose (India) Additional Paid-In Capital Related Terms

Lactose (India) Additional Paid-In Capital Historical Data

* Premium members only.

The historical data trend for Lactose (India)'s Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lactose (India) Additional Paid-In Capital Chart

Lactose (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 130.85 130.85 130.85 130.85 0.00

Lactose (India) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 130.85 0.00 0.00 0.00 0.00
BOM:524202
77GF Score
Lactose (India) Ltd BOM:524202
Additional Paid-In Capital is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lactose (India) Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)
What does a Additional Paid-In Capital of ₹0 Mil mean?
Lactose (India) (BOM:524202) has a Additional Paid-In Capital of ₹0 Mil as of Mar. 2026. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Lactose (India) and its competitors.
Is Lactose (India)'s Additional Paid-In Capital too high?
Lactose (India)'s current Additional Paid-In Capital is ₹0 Mil. Overall, Lactose (India) has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lactose (India)'s Additional Paid-In Capital compare to ZTS?
Lactose (India)'s Additional Paid-In Capital of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Additional Paid-In Capital for a Drug Manufacturers company?
A good Additional Paid-In Capital depends on the Drug Manufacturers industry context. However, Additional Paid-In Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Additional Paid-In Capital mean?
A high Additional Paid-In Capital can signal that a stock is expensive relative to its fundamentals. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Lactose (India) and its competitors. Lactose (India)'s current Additional Paid-In Capital is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lactose (India) stock overvalued right now?
Based on GuruFocus' analysis, Lactose (India) (BOM:524202) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹160.18, compared to a current price of ₹101.30 — trading 36.8% below its estimated fair value. The current Additional Paid-In Capital is ₹0 Mil. Lactose (India)'s overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Additional Paid-In Capital calculated?
Additional Paid-In Capital is calculated from a company's financial statements. For Lactose (India) (BOM:524202), the current Additional Paid-In Capital is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lactose (India) (BOM:524202) Overvalued in 2026?

Based on GuruFocus' analysis, Lactose (India) stock appears to be undervalued. The current stock price of ₹101.30 is trading 36.8% below its estimated GF Value™ of ₹160.18. GuruFocus considers Lactose (India) to be Significantly Undervalued.

Key valuation signals for BOM:524202:

  • Additional Paid-In Capital: ₹0 Mil
  • GF Value™: ₹160.18 vs. price of ₹101.30 (36.8% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the BOM:524202 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lactose (India) Business Description

Address Zakaria Bunder Road, Navbharat Estates, Unit No. G-02, ‘A’ Wing, Ground Floor, Sewri (West), Mumbai, MH, IND, 400015
Lactose (India) Ltd is an India based pharmaceutical company. It is principally engaged in the manufacturing and trading of pharmaceutical products. The company offers pharmaceutical products like Lactose monohydrate, Dry granulated, Film and lacquer coated tablets, Disaccharide lactulose, and Liquid dose form products. Manufacturing of lactose monohydrate and other pharmaceutical products generates revenue for the company. The company sells its products in India and also exports its products internationally.
77GF Score

Get the complete analysis for BOM:524202

Additional Paid-In Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹101.30
Price
₹160.18
GF Value